secwatch.observer — SEC 8-K summary
======================================

Issuer:     Telesis Bio Inc. (—)
CIK:        0001850079
Form:       8-K
Filed at:   2023-07-07T23:59:59+00:00
Accession:  0001193125-23-183769
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Telesis Bio amends debt agreements, raises interest margins; annual meeting elects directors
--------------------------------------------------------------------------------

- Term loan interest margin increased to 6.75% over SOFR (floor 3.50%); prepayment premiums of 3%/2%/1% for years 1-3.
- Revolving loan margin raised to 3.00% over SOFR (floor 3.50%); early termination fee of 3%/2%/1%.
- Minimum net revenue covenant under both loan agreements amended for certain future periods.
- Annual meeting elected Andrea L. Jackson and Franklin R. Witney as Class II directors with ~76% of votes cast.
- Stockholders ratified WithumSmith+Brown as independent auditor for FY 2023; quorum was 81.68%.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1850079/000119312523183769/0001193125-23-183769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1850079/000119312523183769/d514163d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-183769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer